Artal Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Artal Group’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$47.7M	Sell
2024 Q1	$65.1M	Buy
2019 Q2	–	Sell
2019 Q1	$4.55M	Hold
2018 Q4	$6M	Hold
2018 Q3	$5.73M	Buy